Bachem Holding AG Company Description

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.

The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs).

It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services.

Bachem Holding AG was founded in 1971 and is headquartered in Bubendorf, Switzerland.

Bachem Holding AG

Country	Switzerland
Founded	1971
Industry	Medical - Pharmaceuticals
Sector	Healthcare
Employees	2,006
CEO	Thomas Meier

Contact Details

Address: Hauptstrasse 144 Bubendorf, 4416 Switzerland
Phone	41 58 595 2021
Website	bachem.com

Stock Details

Ticker Symbol	0QND
Exchange	London Stock Exchange
Fiscal Year	January - December
Reporting Currency	CHF
ISIN Number	CH1176493729
SIC Code	2833

Key Executives

Name	Position
Thomas Meier	Chief Executive Officer, Chief Operating Officer and Chairman of Group Executive Board
Alain Schaffter	Chief Financial Officer
Michael Suter	Vice President of Global Accounting
Dr. Gunther Loidl	Chief Technology Officer
Achim Pluckebaum	Chief Information Officer
Dr. Daniel Grotzky	Head of Group Communications
Viviane Minden	Chief Human Resources Officer
Dr. Anne-Kathrin Stoller Ph.D.	Chief Operating Officer of Bachem Americas, Inc.
Dr. Torsten Wohr	Chief Commercial Officer
Boris Corpataux	Vice President and Head Global Strategic Alliances